top of page


Beneficial hemoglobin to cure blood diseases

Our Mission

We use genome engineering to develop a cure for the most common deadly monogenic disorders worldwide, the Hemoglobinopathies

At Ariya Bio we focus on hereditary blood diseases and employ cutting-edge genome engineering tools to develop next-generation cell and gene therapies.


Our diverse team of researchers is working every day to bring cutting-edge therapeutics to patients around the world  

Our Programs

"We are working towards a cure for a disease that really needs one"

Mandy Boontanrart

bottom of page